Antiviral immunization of immunocompromised adults, literature review;Vaccination antivirale des adultes immunodéprimés, revue de la littérature

Revue de Medecine Interne

Volumn 29, Issue 7, 2008, Pages 554-567

  Duchet Niedziolka, P ^a,b   Launay, O ^a,b   Salmon Ceron, D ^a   Consigny, P H ^c   Ancelle, T ^a   Van der Vliet, D ^a,b,c   Lortholary, O ^d   Hanslik, T ^b,e  

^a Institut Cochin   (France)

^b INSERM   (France)

^c INSTITUT PASTEUR   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Auto immune disease; Guidelines; Hematopoietic stem cell transplantation; HIV; Immunization; Immunodeficiency; Solid organ transplantation

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; PREDNISONE; TACROLIMUS; VALACICLOVIR; VIRUS VACCINE;

AUTOIMMUNE DISEASE; CHICKENPOX; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENCEPHALITIS; FRANCE; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS A; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOCOMPROMISED PATIENT; IMMUNOGENICITY; INFECTION; ORGAN TRANSPLANTATION; POLIOMYELITIS; SHORT SURVEY; TREATMENT CONTRAINDICATION; VACCINATION;

EID: 45849098343     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2007.08.003     Document Type: Short Survey

References (112)

1. Comité Technique des Vaccinations, section Maladies Transmissibles du Conseil Supérieur d'Hygiène Publique de France. Calendrier vaccinal 2006. BEH 2006;29-30:211-26.
2. Comité Technique des Vaccinations, section Maladies Transmissibles du Conseil Supérieur d'Hygiène Publique de France. Guide des vaccinations 2006.
3. Kotton N.C., Ryan E.T., and Fishman J.A. Prevention of infection in adult travelers after solid organ transplantation. Am J Transplant 5 (2005) 8-14
4. Wraith D.C., Goldman M., and Lambert P.H. Vaccination and autoimmune disease: what is the evidence?. Lancet 362 (2003) 1659-1666
5. Stark K., Gunther M., Schonfeld C., Tullius S.G., and Bienzle U. Immunisations in solid-organ transplant recipients. Lancet 359 (2002) 957-965
6. Duchini A., Goss J.A., Karpen S., and Pockros P.J. Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev 16 (2003) 357-364
7. Huzly D., Neifer S., Reinke P., Schroder K., Schonfeld C., Hofmann T., et al. Routine immunizations in adult renal transplant recipients. Transplantation 63 (1997) 839-845
8. Duchini A., Hendry R.M., Redfield D.C., and Pockros P.J. Influenza infection in patients before and after liver transplantation. Liver Transpl 6 (2000) 531-542
9. Burbach G., Bienzle U., Stark K., Rayes N., Neuhaus R., Serke S., et al. Influenza vaccination in liver transplant recipients. Transplantation 67 (1999) 753-755
10. Mazzone P.J., Mossad S.B., Mawhorter S.D., Mehta A.C., Schilz R.J., and Maurer J.R. The humoral immune response to influenza vaccination in lung transplant patients. Eur Respir J 18 (2001) 971-976
11. Blumberg E.A., Albano C., Pruett T., Isaacs R., Fitzpatrick J., Bergin J., et al. The immunogenicity of influenza vaccine in solid organ transplant recipients. Clin Infect Dis 22 (1996) 295-302
12. Dengler T.J., Strnad N., Buhring I., Zimmermann R., Girgsdies O., Kubler W.E., et al. Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation 66 (1998) 1340-1347
13. Soesman N.M., Rimmelzwaan G.F., Nieuwkoop N.J., Beyer W.E., Tilanus H.W., Kemmeren M.H., et al. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol 61 (2000) 85-93
14. Admon D., Engelhard D., Strauss N., Goldman N., and Zakay-Rones Z. Antibody response to influenza immunization in patients after heart transplantation. Vaccine 15 (1997) 1518-1522
15. Versluis D.J., Beyer W.E., Masurel N., Wenting G.J., and Weimar W. Impairment of the immune response to influenza vaccination in renal transplant recipients by ciclosporine, but not azathioprine. Transplantation 42 (1986) 376-379
16. Wagner C.R., and Hosenpud J.D. Enhanced lymphocyte proliferative responses to donor-specific aortic endothelial cells following influenza vaccination. Transpl Immunol 1 (1993) 83-85
17. Blumberg E.A., Fitzpatrick J., Stutman P.C., Hayden F.G., and Brozena S.C. Safety of influenza vaccine in heart transplant recipients. J Heart Lung Transplant 17 (1998) 1075-1080
18. Samuel D., Muller R., Alexander G., Fassati L., Ducot B., Benhamou J.P., et al. Liver transplantation in European patients with hepatitis B surface antigen. N Engl J Med 329 (1993) 1842-1847
19. Segovia R., Sanchez-Fueyo A., Rimola A., Grande L., Bruguera M., Costa J., et al. Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation. Liver Transpl 7 (2001) 106-112
20. Chalasani N., Smallwood G., Halcomb J., Fried M.W., and Boyer T.D. Is vaccination against hepatitis B infection indicated in patients waiting for or after orthopic liver transplantation?. Liver Transpl Surg 4 (1998) 128-132
21. Loinaz C., de Juanes J.R., Gonzalez E.M., Lopez A., Lumbreras C., Gomez R., et al. Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology 44 (1997) 235-238
22. Wagner D., Wagenbreth I., Stachan-Kunstyr R., and Flik J. Failure of vaccination against hepatitis B with Gen H-B-Vax-D in immunosuppressed heart transplant recipients. Clin Investig 70 (1992) 585-587
23. Lefebure A.F., Verpooten G.A., Couttenye M.M., and De Broe M.E. Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients. Vaccine 11 (1993) 397-399
24. Keeffe E. Hepatitis A in patients with chronic liver disease-severity of illness and prevention with vaccination. J Viral Hepat 7 Suppl 1 (2000) 15-17
25. Stark K., Gunther M., Neuhaus R., Reinke P., Schroder K., Linnig S., et al. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J Infect Dis 180 (1999) 2014-2017
26. Gunther M., Stark K., Neuhaus R., Reinke P., Schroder K., and Bienzle U. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation 71 (2001) 477-479
27. Dumot J.A., Barnes D.S., Younossi Z., Gordon S.M., Avery R.K., Domen R.E., et al. Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am J Gastroenterol 94 (1999) 1601-1604
28. Advisory Committee on Immunization Practices. Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999; 48(RR-6):1-5.
29. Zamora I., Simon J.M., Da Silva M.E., and Piqueras A.I. Attenuated varicella virus vaccine in children with renal transplants. Pediatr Nephrol 8 (1994) 190-192
30. Rand E.B., McCarthy C.A., and Whitington P.F. Measles vaccination after orthopic liver transplantation. J Pediatr 123 (1993) 87-89
31. es Journées Nationales d'Infectiologie. Bordeaux juin 2006. Med Mal Infect 36 Suppl 1 (2006) S143
32. Dengler T.J., Zimmermann R., Meyer J., Sack F.U., Girgsdies O., and Kubler W.E. Vaccination against tick borne encephalitis under therapeutic immunosuppression. Reduced efficacy in heart transplant recipients. Vaccine 17 (1999) 867-874
33. Ljungman P., Engelhard D., de la Cámara R., Einsele H., Locasciulli A., Martino R., et al. Infectious diseases working party of the european group for blood and marrow transplantation. Vaccination of stem cell transplant recipients: recommendations of the infectious diseases working party of the EBMT. Bone Marrow Transplant 35 (2005) 737-746
34. Somani J., and Larson R.A. Reimmunization after allogeneic bone marrow transplantation. Am J Med 98 (1995) 389-398
35. Centers for Disease Control and Prevention (CDC). Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Disease society of America, and the American Society of blood and Marrow Transplantation. MMWR Morb Mortal Wkly Rep 2000; 49(RR-10):1-125.
36. Ljungman P., Duraj V., and Magnius L. Response to immunization against polio after allogeneic marrow transplantation. Bone Marrow Transplant 7 (1991) 89-93
37. Pauksen K., Hammarström V., Ljungman P., Sjölin J., Oberg G., Lönnerholm G., et al. Immunity to poliovirus and immunization with inactivated poliovirus vaccine after autologous bone marrow transplantation. Clin Infect Dis 18 (1994) 547-552
38. Parkkali T., Stenvik M., Ruutu T., Hovi T., Volin L., and Ruutu P. Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT. Bone Marrow Transplant 20 (1997) 663-668
39. Engelhard D., Nagler A., Hardan I., Morag A., Aker M., Baciu H., et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant 11 (1993) 1-5
40. Dhédin N., Douvin C., Kuentz M., Saint Marc M.F., Reman O., Rieux C., et al. Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc. Transplantation 66 (1998) 616-619
41. Locasciulli A., Alberti A., Bandini G., Polchi P., Arcese W., Alessandrino P., et al. Allogeneic bone marrow transplantation from HBsAg+ donors: a multicenter study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Blood 86 (1995) 3236-3240
42. Hanslik T., Blanchon T., and Alvarez F.P. Vaccination des adultes contre la varicelle et le zona. Rev Med Interne 28 (2007) 166-172
43. Sauerbrei A., Prager J., Hengst U., Zintl F., and Wutzler P. Varicella vaccination in children after bone marrow transplantation. Bone Marrow Transplant 20 (1997) 381-383
44. Ljungman P., Wang F.Z., Nilsson C., Solheim V., and Linde A. Vaccination of autologous stem cell transplant recipients with live varicella vaccine: a pilot study. Support Care Cancer 11 (2003) 739-741
45. Ljungman P., Fridell E., Lönnqvist B., Bolme P., Böttiger M., Gahrton G., et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 159 (1989) 610-615
46. Spoulou V., Giannaki M., Vounatsou M., Bakoula C., and Grafakos S. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants. Bone Marrow Transplant 33 (2004) 1187-1190
47. Machado C.M., Gonçalves F.B., Pannuti C.S., Dulley F.L., and de Souza V.A. Measles in bone marrow transplant recipients during an outbreak in São Paulo, Brazil. Blood 99 (2002) 83-87
48. Gowda R., Cartwright K., Bremner J.A., and Green S.T. Yellow fever vaccine: a successful vaccination of an immunocompromised patient. Eur J Haematol 72 (2004) 299-301
49. Yéni P, éd. Prise en charge médicale des personnes infectées par le VIH. Recommandations du groupe d'experts. Rapport 2006. Paris : Médecine Sciences, Flammarion ; 2006.
50. Oliveira Fonseca M., Wayie Pang L., de Paula Cavalheiro N., Alci Barone A., and Heloisa Lopes M. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. Vaccine 23 (2005) 2902-2908
51. Kroon F.P., Rimmelzwaan G.F., Roos M.T., Osterhaus A.D., Hamann D., Miedema F., et al. Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy. AIDS 12 (1998) F217-F223
52. Zanetti A.R., Amendola A., Besana S., Boschini A., and Tanzi E. Safety and immunogenicity of influenza vaccination in individuals infected with HIV. Vaccine 20 Suppl 5 (2002) B29-B32
53. Tasker S.A., Treanor J.J., Paxton W.B., and Wallace M.R. Efficacy of influenza vaccination in HIV-infected persons. A randomised, double-blind, placebo-controlled trial. Ann Intern Med 131 (1999) 430-433
54. Sullivan P.S., Hanson D.L., Dworkin M.S., Jones J.L., and Ward J.W. Adult and Adolescent Spectrum of HIV Disease Investigators. Effect of influenza vaccination on disease progression among HIV-infected persons. AIDS 14 (2000) 2781-2785
55. Skiest D.J., and Machala T. Comparison of the effects of acute influenza infection and influenza vaccination on HIV viral load and CD4 cell counts. J Clin Virol 26 (2003) 307-315
56. Glesby M.J., Hoover D.R., Farzadegan H., Margolick J.B., and Saah A.J. The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study. J Infect Dis 174 (1996) 1332-1336
57. Kroon F.P., van Dissel J.T., Labadie J., van Loon A.M., and van Furth R. Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus. Clin Infect Dis 21 (1995) 1197-1203
58. Bouchaud O. Vaccinations chez les patients immunodéprimés. Ann Med 148 (1997) 272-278
59. Advisory Committee on Immunization Practices; Smith NM, Bresee JS, Shay DK, Uyeki TM, Cox NJ, Strikas RA. Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55(RR-10):1-42.
60. Iorio A.M., Alatri A., Francisci D., Preziosi R., Neri M., Donatelli I., et al. Immunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users. Vaccine 15 (1997) 97-102
61. Kroon F.P., van Dissel J.T., de Jong J.C., and van Furth R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 8 (1994) 469-476
62. Tasker S.A., O'Brien W.A., Treanor J.J., Weiss P.J., Olson P.E., Kaplan A.H., et al. Effects of influenza vaccination in HIV-infected adults: a double-bind, placebo-controlled trial. Vaccine 16 (1998) 1039-1042
63. Laurence J.C. Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus. Am J Med 118 Suppl 10A (2005) 75S-83S
64. Locke R.H., Murray-Lyon I.M., Coleman J.C., Evans B.A., and Zuckerman A.J. Diminished response to recombinant hepatitis B vaccine in homosexual men with antibody: an indicator of poor prognosis. J Med Virol 31 (1990) 109-111
65. Cornejo-Juarez P., Volkow-Fernandez P., Escobedo-Lopez K., Vilar-Compte D., Ruiz-Palacios G., and Soto-Ramirez L.E. Randomized controlled trial of hepatitis B virus vaccine in HIV 1 infected patients comparing two different doses. AIDS Res Ther 3 (2006) 9
66. Rey D., Krantz V., Partisani M., Schmitt M.P., Meyer P., Libbrecht E., et al. Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. Vaccine 18 (2000) 1161-1165
67. Ristola M.A., Vuola J.M., Valle M., and von Reyn C.F. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects. Vaccine 23 (2004) 205-209
68. Advisory Committee on Immunization Practices. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence, MMWR Recomm Rep 1993; 42(RR-4):1-18.
69. Wallace M.R., Brandt C.J., Earhart K.C., Kuter B.J., Grosso A.D., Lakkis H., et al. Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects. Clin Infect Dis 39 (2004) 1207-1213
70. Kemper C.A., Haubrich R., Frank I., Dubin G., Buscarino C., McCutchan J.A., et al. Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial. J Infect Dis 187 (2003) 1327-1331
71. Bodsworth N.J., Neilsen G.A., and Donovan B. The effect of immunization with inactivated hepatitis A vaccine on the clinical course of HIV-1 infection: 1-year follow-up. AIDS 11 (1997) 747-749
72. Advisory Committee on Immunization Practices (ACIP), CDC. Prevention of varicella; recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56(RR-4):1-40.
73. Levin M.J., Gershon A.A., Weinberg A., Song L.Y., Fentin T., Nowak B., and Pediatric AIDS Clinical Trials Group 265 Team. Administration of live varicella vaccine to HIV infected children with current or past significant depression of CD4+ T cells. J Infect Dis 194 (2006) 247-255
74. Centers for Disease Control and Prevention (CDC). Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993. MMWR Morb Mortal Wkly Rep1996;45:603-6.
75. Watson J.C., Hadler S.C., Dykewicz C.A., Reef S., and Phillips L. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 47 RR-8 (1998) 21-22
76. Wallace M.R., Hooper D.G., Graves S.J., and Malone J.L. Measles seroprevalence and vaccine response in HIV-infected adults. Vaccine 12 (1994) 1222-1224
77. Tattevin P., Depatureaux A.G., Chapplain J.M., Dupont M., Souala F., Arvieux C., et al. Yellow fever vaccine is safe and effective in HIV infected patients. AIDS 18 (2004) 825-827
78. Receveur M.C., Thiébaut R., Vedy S., Malvy D., Mercie P., and Bras M.L. Yellow fever vaccination of human immunodeficiency virus infected patients: report of 2 cases. Clin Infect Dis 31 (2000) E7-E8
79. Pistone T., Verdière M.C., Receveur M.C., Ezzedine K., Lafon M.E., and Malvy D. Immunogénicité et tolérance du vaccin amaril chez le voyageur vivant avec le VIH, France, 2005. Bull Épidémiol Hebd thématique 25-26 (2007) 238-240
80. Cetron M.S., Marfin A.A., Julian K.G., Gubler D.J., Sharp D.J., Barwick R.S., et al. Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep 52 RR-17 (2002) 7-8
81. Kengsakul K., Sathirapongsasuti K., and Punyagupta S. Fatal myeloencephalitis following yellow fever vaccination in case with HIV infection. J Med Assoc Thai 85 (2002) 131-134
82. Tantawichien T., Jaijaroensup W., Khawplod P., and Sitprija V. Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+T lymphocyte counts. Clin Infect Dis 33 (2001) E122-E124
83. Panasiuk B., Prokopowicz D., and Panasiuk A. Immunological response in HIV-positive patients vaccinated against tick borne encephalitis. Infection 31 (2003) 45-46
84. Rojanasuphot S., Shaffer N., Chotpitayasunondh T., Phumiamorn S., Mock P., Chearskul S., et al. Response to JE vaccine among HIV-infected children, Bangkok, Thailand. Southeast Asian J Trop Med Public Health 29 (1998) 443-450
85. Hanslik T., Boulard J.C., and Baglin A. Vaccination et maladies immunologiques. Rev Med Interne 17 (1996) 17-20
86. Kubiet M.A., Gonzalez-Rothi R.J., Cottey R., and Bender B.S. Serum antibody response to influenza vaccine in pulmonary patients receiving corticosteroids. Chest 110 (1996) 367-370
87. Hanania N.A., Sockrider M., Castro M., Holbrook J.T., Tonascia J., Wise R., et al. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol 113 (2004) 717-724
88. Fomin I., Caspi D., Levy V., Varsano N., Shalev Y., Paran D., et al. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis 65 (2006) 191-194
89. Kapetanovic M.C., Saxne T., Nilsson J.A., and Geborek P. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford) 46 (2007) 608-611
90. Kaine J.L., Kivitz A.J., Birbara C., and Luo A.Y. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol 34 (2007) 272-279
91. Schattner A., Ben-Chetrit E., and Schmilovitz H. Poliovaccines and the course of systemic lupus erythematosus - a retrospective study of 73 patients. Vaccine 10 (1992) 98-100
92. Holvast B., Huckriede A.L., Wilschut J., Horst G., De Vries J.J., Benne C.A., et al. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis 65 (2006) 913-918
93. Mercado U., Acosta H., and Avendano L. Influenza vaccination of patients with systemic lupus erythematosus. Rev Invest Clin 56 (2004) 16-20
94. Abu-Shakra M., Press J., Varsano N., Levy V., Mendelson E., Sukenik S., et al. Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol 29 (2002) 2555-2557
95. Turner-Stokes L., and Isenberg D.A. Immunisation of patients with rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 47 (1988) 529-531
96. Brodman R., Gilfillan R., Glass D., and Schur P.H. Influenzal vaccine response in systemic lupus erythematosus. Ann Intern Med 88 (1978) 735-740
97. Ristow S.C., Douglas Jr. R.G., and Condemi J.J. Influenza vaccination of patients with systemic lupus erythematosus. Ann Intern Med 88 (1978) 786-789
98. Louie J.S., Nies K.M., Shoji K.T., Fraback R.C., Abrass C., Border W., et al. Clinical and antibody responses after influenza immunization in systemic lupus erythematosus. Ann Intern Med 88 (1978) 790-792
99. Williams G.W., Steinberg A.D., Reinertsen J.L., Klassen L.W., Decker J.L., and Dolin R. Influenza immunization in systemic lupus erythematosus. A double blind trial. Ann Intern Med 88 (1978) 729-734
100. Myers L.W., Ellison G.W., Lucia M., Novom S., Holevoet M., Madden D., et al. Swine influenza virus vaccination in patients with multiple sclerosis. J Infect Dis 136 Suppl (1977) S546-S554
101. Schwid S.R., Decker M.D., and Lopez-Bresnahan M. Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-a1. Neurology 65 (2005) 1964-1966
102. Chalmers A., Scheifele D., Patterson C., Williams D., Weber J., Shuckett R., et al. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol 21 (1994) 1203-1206
103. Miller A.E., Morgante L.A., Buchwald L.Y., Nutile S.M., Coyle P.K., Krupp L.B., et al. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology 48 (1997) 312-314
104. Abu-Shakra M., Press J., Sukenik S., and Buskila D. Influenza virus vaccination of patients with SLE: effects on generation of autoantibodies. Clin Rheumatol 21 (2002) 369-372
105. Abu-Shakra M., Zalmanson S., Neumann L., Flusser D., Sukenik S., and Buskila D. Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity. J Rheumatol 27 (2000) 1681-1685
106. Gartner S, Emlen W, Hepatitis B vaccination of SLE patients [abstracts]. Procedings of the ACR Congress, Orlando, October 1996. Ann Rheum Dis 1996; 39 Suppl: 291.
107. Elkayam O., Yaron M., and Caspi D. Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis. Ann Rheum Dis 61 (2002) 623-625
108. Erkek E., Ayaslioglu E., Erkek A.B., Kurtipek G.S., and Bagci Y. Response to vaccination against hepatitis B in patients with Behcet's disease. J Gastroenterol Hepatol 20 (2005) 1508-1511
109. Confavreux C., Suissa S., Saddier P., Bourdes V., Vukusic S., and Vaccines in Multiple Sclerosis Study Group. Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in multiple sclerosis study group. N Engl J Med 344 (2001) 319-326
110. Atkinson W.L., Pickering L.K., Schwartz B., Weniger B.G., Iskander J.K., Watson J.C., and Centers for Disease Control and Prevention. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR Recomm Rep 51 RR-2 (2002) 22-23
111. British Society for Rheumatology (BSR). Vaccinations in the immunocompromised person: guidelines for the patient taking immunosuppressants, steroids and the new biologic therapies. BSR 2002 : http://www.rheumatology.org.uk/guidelines/clinicalguidelines.
112. Palefsky J.M., Gillison M.L., and Strickler H.D. Chapter 16: HPV vaccines in immunocompromised women and men. Vaccine 3 Suppl (2006) 140-146